DanDrit Biotech USA Inc Stock OTC Bulletin Board
Equities
US2360781015
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Apr. 18 | Renovaro Inc. Announces Geert Kazemier, MD, PhD, as the New Chairman of its Scientific Advisory Board | CI |
Mar. 13 | Renovaro Inc. Appoints Simon Tarsh as Interim Chief Financial Officer | CI |
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 34.41M |
---|---|---|---|---|---|
Net income 2022 | -113M | Net income 2023 | -39M | EV / Sales 2022 | - |
Net cash position 2022 | 1.99M | Net Debt 2023 | 3.9M | EV / Sales 2023 | - |
P/E ratio 2022 |
-0.89
x | P/E ratio 2023 |
-0.8
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 73.77% |
Managers | Title | Age | Since |
---|---|---|---|
Mark Dybul
CEO | Chief Executive Officer | 60 | 18-01-22 |
Lester Russell
CTO | Chief Tech/Sci/R&D Officer | - | 23-08-20 |
Greg Duczynski
CTO | Chief Tech/Sci/R&D Officer | - | 15-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gregg Alton
BRD | Director/Board Member | 58 | 19-12-31 |
Avram Miller
BRD | Director/Board Member | - | 23-10-10 |
James Sapirstein
BRD | Director/Board Member | 62 | 18-03-05 |
1st Jan change | Capi. | |
---|---|---|
-3.78% | 102B | |
+1.56% | 96.07B | |
-1.80% | 21.66B | |
-17.41% | 20.77B | |
-6.91% | 18.53B | |
-42.00% | 16.91B | |
-28.05% | 13.79B | |
-1.05% | 13.33B | |
+18.83% | 10.94B |